Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lurasidone Effects on Tissue Glutamate in Schizophrenia
NCT02199743Phase 4Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Feb 2013
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lurasidone in schizophrenia, schizoaffective disorder, sponsored by UT Southwestern Medical Center. Started Feb 2013; status: completed.
02
Drugs
lurasidone
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT02199743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02199743.